Low serum levels of soluble RANK ligand are associated with the presence of coronary artery disease in men

被引：57

作者：

Schoppet, M ^{[1
]}

Schaefer, JR ^{[1
]}

Hofbauer, LC ^{[1
]}

机构：

[1] Univ Marburg, Dept Internal Med, D-3550 Marburg, Germany

来源：

CIRCULATION | 2003年 / 107卷 / 11期

关键词：

D O I：

10.1161/01.CIR.0000060815.25798.02

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E76 / E76

页数：1

共 5 条

[1] Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women [J].

Browner, WS ;

Lui, LY ;

Cummings, SR .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (02) :631-637

[2] Osteoprotegerin: a link between osteoporosis and arterial calcification? [J].

Hofbauer, LC ;

Schoppet, M .

LANCET, 2001, 358 (9278) :257-259

[3] Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease [J].

Jono, S ;

Ikari, Y ;

Shioi, A ;

Mori, K ;

Miki, T ;

Hara, K ;

Nishizawa, Y .

CIRCULATION, 2002, 106 (10) :1192-1194

[4] Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis [J].

Min, H ;

Morony, S ;

Sarosi, I ;

Dunstan, CR ;

Capparelli, C ;

Scully, S ;

Van, G ;

Kaufman, S ;

Kostenuik, PJ ;

Lacey, DL ;

Boyle, TJ ;

Simonet, WS .

JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (04) :463-474

[5] Increased osteoprotegerin serum levels in men with coronary artery disease [J].

Schoppet, M ;

Sattler, AM ;

Schaefer, JR ;

Herzum, M ;

Maisch, B ;

Hofbauer, LC .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (03) :1024-1028

← 1 →